Arca
Skip to content

Mixed dyslipidemia

Drug research and approvals for mixed dyslipidemia: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 14 studies of mixed dyslipidemia are recruiting on ClinicalTrials.gov, and Health Canada has authorized 7 drug trials for it since 2013.

  • Recruiting worldwide: 14
  • Trials authorized in Canada: 7
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 14 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
Mar 1, 2022A phase 2, randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of ly3561774 in adults with mixed dyslipidemiaSOLBINSIRAN (LY3561774)Eli LillyClosed
Sep 1, 2021A double-blind, placebo-controlled phase 2b study to evaluate the efficacy and safety of aro-apoc3 in adults with mixed dyslipidemiaADS-005 (ARO-APOC3)ARROWHEAD PHARMACEUTICALS, INC.Closed
Jun 1, 2016A double blind, randomized, placebo controlled, multicenter study to evaluate safety, tolerability, and efficacy on ldl-c of evolocumab (amg 145) in subjects…REPATHAAmgenOngoing
Apr 29, 2016A double-blind, randomized, placebo-controlled, multicenter study to evaluate safety, tolerability, and efficacy of evolocumab (amg 145) on ldl-c in subjects…REPATHAAmgenClosed
Oct 10, 2014A 52 week, phase 3, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy, safety and tolerability of pf-04950615 in…RN316 (PF-04950615)PfizerOngoing
May 16, 2014A phase 3 double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy, long-term safety and tolerability of pf-04950615 in…RN316 (PF-04950615)PfizerClosed
Apr 24, 2013"a multicenter, controlled, open-label extension (ole) study to assess the long-term safety and efficacy of amg 145."AMG 145AmgenOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.